Skip to main content

Movers & Shakers: May 7, 2009

Premium

David Harvey is retiring as chairman of Sigma-Aldrich's board, the company said this week, and will be replaced by President and CEO Jai Nagarkatti.

Harvey's retirement took effect earlier this week. He will remain a director. He joined Sigma-Aldrich in 1974 and has served in a number of roles at the firm, including president from 1995 to 2004, CEO from 1999 to 2005, and chairman starting in 2001. He has been a director at the company since 1981.

Nagarkatti joined Sigma-Aldrich in 1976, and was elected president and chief operating officer in 2004. He became CEO in 2006 and has been a director since 2005.

The company also appointed Barrett Toan, currently a director to presiding director. He is the former chairman of pharmacy benefit management firm Express Scripts and has been a director since 2001.

Also re-elected as directors this week were Rebecca Bergman, Lee McCollum, Avi Nash, Steven Paul, Pedro Reinhard, Timothy Sear, and Dean Spatz.


Xiangdong Feng and Xia Wang will join the National Cancer Institute's Clinical Proteomic Technology Assessment for Cancer program as postdoctoral fellows, the National Institute of Statistical Sciences announced this week.

NISS is providing statistical expertise and guidance on the CPTAC project and for the next 2.5 years will develop specific statistical methodology for proteomics research. Feng and Wang were appointed to the CPTAC project by NISS. In total, six new postdocs were appointed by NISS this week.

Feng received his PhD in statistics from the University of Illinois, Urbana-Champaign. Wang holds a PhD in statistics from the University of Connecticut.

The Scan

Possibly as Transmissible

Officials in the UK say the B.1.617.2 variant of SARS-CoV-2 may be as transmitted as easily as the B.1.1.7 variant that was identified in the UK, New Scientist reports.

Gene Therapy for SCID 'Encouraging'

The Associated Press reports that a gene therapy appears to be effective in treating severe combined immunodeficiency syndrome.

To Watch the Variants

Scientists told US lawmakers that SARS-CoV-2 variants need to be better monitored, the New York Times reports.

Nature Papers Present Nautilus Genome, Tool to Analyze Single-Cell Data, More

In Nature this week: nautilus genome gives peek into its evolution, computational tool to analyze single-cell ATAC-seq data, and more.